View Single Post
Old Sun May 15, 2011, 04:45 AM
Birgitta-A Birgitta-A is offline
Join Date: Oct 2007
Location: Stockholm, Sweden
Posts: 1,918

Hi Sally,
You are right about the concern about the risk for fibrosis - they have now started the third trial for MDS patients and the second for AA patients.

I suppose Don is in this trial:

You know when the two new drugs for low platelets were approved I was hoping that they would soon be in trials for MDS because they were in trials for several other diseases with low platelets due to chemo like Hepatitis C. Then I was scared because of the reports about increased fibrosis and blasts after treatment with Nplate. At that time I wrote that platelet transfusions were safer though I know that most patients won't have a good effect after many platelet transfusions. Now I have changed my mind again - perhaps Promacta will be a good drug for MDS patients.

Hope Don will have a positive response!
Kind regards
Reply With Quote